Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

311 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Guidelines for the treatment of childhood IgA nephropathy].
Yoshikawa N, Igarashi T, Ishikura K, Kaku Y, Nakazato H, Kamei K, Kawamura T, Nakamura H, Yamamoto Y, Nakanishi K, Sako M. Yoshikawa N, et al. Among authors: ishikura k. Nihon Jinzo Gakkai Shi. 2008;50(1):31-41. Nihon Jinzo Gakkai Shi. 2008. PMID: 18318242 Japanese. No abstract available.
Long-term results of a randomized controlled trial in childhood IgA nephropathy.
Kamei K, Nakanishi K, Ito S, Saito M, Sako M, Ishikura K, Hataya H, Honda M, Iijima K, Yoshikawa N; Japanese Pediatric IgA Nephropathy Treatment Study Group. Kamei K, et al. Among authors: ishikura k. Clin J Am Soc Nephrol. 2011 Jun;6(6):1301-7. doi: 10.2215/CJN.08630910. Epub 2011 Apr 14. Clin J Am Soc Nephrol. 2011. PMID: 21493743 Free PMC article. Clinical Trial.
Efficacy and safety of lisinopril for mild childhood IgA nephropathy: a pilot study.
Nakanishi K, Iijima K, Ishikura K, Hataya H, Awazu M, Sako M, Honda M, Yoshikawa N; Japanese Pediatric IgA Nephropathy Treatment Study Group. Nakanishi K, et al. Among authors: ishikura k. Pediatr Nephrol. 2009 Apr;24(4):845-9. doi: 10.1007/s00467-008-1006-8. Epub 2008 Sep 30. Pediatr Nephrol. 2009. PMID: 18825420 Clinical Trial.
A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment.
Yoshikawa N, Nakanishi K, Sako M, Oba MS, Mori R, Ota E, Ishikura K, Hataya H, Honda M, Ito S, Shima Y, Kaito H, Nozu K, Nakamura H, Igarashi T, Ohashi Y, Iijima K; Japanese Study Group of Kidney Disease in Children. Yoshikawa N, et al. Among authors: ishikura k. Kidney Int. 2015 Jan;87(1):225-32. doi: 10.1038/ki.2014.260. Epub 2014 Jul 23. Kidney Int. 2015. PMID: 25054775 Free PMC article. Clinical Trial.
Combination therapy with or without warfarin and dipyridamole for severe childhood IgA nephropathy: an RCT.
Shima Y, Nakanishi K, Kaku Y, Ishikura K, Hataya H, Matsuyama T, Honda M, Sako M, Nozu K, Tanaka R, Iijima K, Yoshikawa N; Japanese Pediatric IgA Nephropathy Treatment Study Group. Shima Y, et al. Among authors: ishikura k. Pediatr Nephrol. 2018 Nov;33(11):2103-2112. doi: 10.1007/s00467-018-4011-6. Epub 2018 Jul 9. Pediatr Nephrol. 2018. PMID: 29987456 Clinical Trial.
Lisinopril versus lisinopril and losartan for mild childhood IgA nephropathy: a randomized controlled trial (JSKDC01 study).
Shima Y, Nakanishi K, Sako M, Saito-Oba M, Hamasaki Y, Hataya H, Honda M, Kamei K, Ishikura K, Ito S, Kaito H, Tanaka R, Nozu K, Nakamura H, Ohashi Y, Iijima K, Yoshikawa N; Japanese Study Group of Kidney Disease in Children (JSKDC). Shima Y, et al. Among authors: ishikura k. Pediatr Nephrol. 2019 May;34(5):837-846. doi: 10.1007/s00467-018-4099-8. Epub 2018 Oct 3. Pediatr Nephrol. 2019. PMID: 30284023 Clinical Trial.
Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.
Iijima K, Sako M, Nozu K, Mori R, Tuchida N, Kamei K, Miura K, Aya K, Nakanishi K, Ohtomo Y, Takahashi S, Tanaka R, Kaito H, Nakamura H, Ishikura K, Ito S, Ohashi Y; Rituximab for Childhood-onset Refractory Nephrotic Syndrome (RCRNS) Study Group. Iijima K, et al. Among authors: ishikura k. Lancet. 2014 Oct 4;384(9950):1273-81. doi: 10.1016/S0140-6736(14)60541-9. Epub 2014 Jun 22. Lancet. 2014. PMID: 24965823 Clinical Trial.
Study protocol: multicenter double-blind, randomized, placebo-controlled trial of rituximab for the treatment of childhood-onset early-stage uncomplicated frequently relapsing or steroid-dependent nephrotic syndrome (JSKDC10 trial).
Nagano C, Sako M, Kamei K, Ishikura K, Nakamura H, Nakanishi K, Omori T, Nozu K, Iijima K. Nagano C, et al. Among authors: ishikura k. BMC Nephrol. 2019 Aug 2;20(1):293. doi: 10.1186/s12882-019-1470-3. BMC Nephrol. 2019. PMID: 31375087 Free PMC article.
311 results